July 10, 2019 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans; OTCQX: IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, today announced its revenue for the second quarter and the first half of 2019. € ‘000s – IFRS*20192018ChangeTotal first-quarter revenue1,9041,867+2%Second-quarter   Spine (JAZZ®)1,2441,148+8%Knee670617+9%Total …